The response deadline has passed. Review the details for future reference or to track similar opportunities.
The VA Portland Healthcare System (VHAPORHCS) Pathology & Laboratory Medicine Service Department requires continued access to specialized testing for Measurable Residual Disease (MRD) detection in hematologic malignancies.
MRD is a powerful diagnostic and prognostic tool that quantifies the presence of residual cancer cells during and after treatment in patients with multiple myeloma, B-cell acute lymphoblastic leukemia (B-ALL), and chronic lymphocytic leukemia (CLL).
Hector Gonzalez to this opportunity.
Get matched to contracts like this daily
Free AI-powered contract matching for your business.